Traveling the Vitamin B₁₂ Pathway: Oral Delivery of Protein and Peptide Drugs
Oral routes of administration for therapeutic peptides and proteins face two major barriers: proteolytic degradation in the stomach and an inadequate absorption mechanism for polypeptides within the intestinal lumen. As a result, peptide-based therapeutics are administered by injection, a painful pr...
Saved in:
Published in | Angewandte Chemie (International ed.) Vol. 48; no. 6; pp. 1022 - 1028 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley-VCH Verlag
26.01.2009
WILEY-VCH Verlag WILEY‐VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Oral routes of administration for therapeutic peptides and proteins face two major barriers: proteolytic degradation in the stomach and an inadequate absorption mechanism for polypeptides within the intestinal lumen. As a result, peptide-based therapeutics are administered by injection, a painful process associated with lower patient compliance. The development of a means of overcoming these two major obstacles and enabling the successful delivery of peptide therapeutics by the oral route of administration has therefore been the target of extensive scientific endeavor. This Minireview focuses on oral peptide/protein delivery by the dietary uptake pathway for vitamin B₁₂. Recent progress in this field includes the delivery of erythropoietin, granulocyte-colony-stimulating factor, luteinizing-hormone-releasing hormone, and insulin. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/anie.200800865 istex:065CDA5236645F0E94AC33B0F56BD169FF6F5C18 ArticleID:ANIE200800865 ark:/67375/WNG-57L72S34-G ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.200800865 |